ABUS: Arbutus Biopharma Corp

FinancialsDividends

$3.24

0.07

(2.21%)

As of 07/14/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

ABUS Performance Snapshot

1-Week Chg

3.18%

1-Month Chg

-8.22%

3-Month Chg

-1.22%

6-Month Chg

1.89%

1-Year Chg

-9.75%

Year-To-Date Chg

-1.52%

Beta 1-Year

-0.04

Beta 5-Year

0.83

Volatility (10-Day)

2.13%

ABUS Technical Snapshot

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-07-14

$3.24

$0.07 (2.21%)

$3.15

$3.25

$3.14

$3.21

659.00K ($2.14M)

2025-07-11

$3.17

-$0.11 (-3.35%)

$3.25

$3.26

$3.10

$3.18

1.13M ($3.57M)

2025-07-10

$3.28

-$0.06 (-1.8%)

$3.32

$3.33

$3.23

$3.28

860.00K ($2.82M)

2025-07-09

$3.34

$0.16 (5.03%)

$3.23

$3.36

$3.21

$3.30

1.17M ($3.90M)

2025-07-08

$3.18

$0.04 (1.27%)

$3.15

$3.23

$3.12

$3.18

544.00K ($1.73M)

2025-07-07

$3.14

-$0.10 (-3.09%)

$3.22

$3.24

$3.11

$3.16

599.00K ($1.88M)

2025-07-03

$3.24

$0.05 (1.57%)

$3.20

$3.28

$3.19

$3.24

354.00K ($1.15M)

2025-07-02

$3.19

$0.01 (0.31%)

$3.18

$3.28

$3.15

$3.21

600.00K ($1.91M)

2025-07-01

$3.18

$0.09 (2.91%)

$3.07

$3.23

$3.06

$3.16

893.00K ($2.84M)

2025-06-30

$3.09

-$0.04 (-1.28%)

$3.12

$3.12

$3.04

$3.08

1.13M ($3.48M)

ABUS Financial Snapshot

Balance Sheet

(USD)

2025 Q1

Y/Y CHANGE

  • Cash and equivalents

    $37.08M

    -13.98%

  • Total assets

    $117.01M

    -22.14%

  • Total liabilities

    $37.85M

    6.17%

  • Total investments

    $75.63M

    -20.23%

  • Shareholders' equity

    $79.16M

    -30.95%

  • Book value per share

    $0.41

    -36.45%

Income Statement

(USD)

2025 Q1

Y/Y CHANGE

  • Revenue

    $1.76M

    15.14%

  • Net income

    -$24.53M

    -37.21%

  • Operating expense

    $27.16M

    31.13%

  • Gross profit

    $1.76M

    15.14%

  • EBITDA

    -$24.17M

    -38.29%

  • Earnings per share

    -$0.13

    -30.00%

Cash Flow

(USD)

2025 Q1

Y/Y CHANGE

  • Net change in cash

    $746.00K

    -95.56%

  • Cash from operations

    -$13.39M

    30.60%

  • Cash from investing

    $11.35M

    -2.95%

  • Cash from financing

    $2.78M

    -88.60%

  • Free cash flow

    -$13.39M

    30.94%

  • Free cash flow per share

    -$0.07

    36.36%

Metrics

(USD)

2025 Q1

Y/Y CHANGE

  • Market capitalization

    $668.27M

    44.31%

  • Enterprise value

    $638.05M

    43.21%

  • Shares outstanding

    191.48M

    6.68%

  • Profit margin

    -1390.40%

    -19.16%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    -1370.10%

    -20.11%

Dividends

(USD)

2025 Q1

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    6.01

    -10.22%

View Financial Statements